Rezultati - Lijin Zhao

  • Showing 1 - 3 results of 3
Refine Results
  1. 1
    Significant Response to Palbociclib Plus Lenvatinib as Second-line Treatment for CDKN2A/2B Deletion Intrahepatic Cholangiocarcinoma: A Case Report

    Significant Response to Palbociclib Plus Lenvatinib as Second-line Treatment for CDKN2A/2B Deletion Intrahepatic Cholangiocarcinoma: A Case Report od Kai Liu, Ziyue Huang, Lijin Zhao, Haitao Zhao

    Izdano 2025
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  2. 2
    TLR9 regulates NLRP3 inflammasome activation via the NF-kB signaling pathway in diabetic nephropathy

    TLR9 regulates NLRP3 inflammasome activation via the NF-kB signaling pathway in diabetic nephropathy od Jin-feng Shen, Zaiyou Dai, Yunsheng Li, Huiping Zhu, Lijin Zhao

    Izdano 2022
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  3. 3
    Immunotherapy in hepatocellular carcinoma: an overview of immune checkpoint inhibitors, drug resistance, and adverse effects

    Immunotherapy in hepatocellular carcinoma: an overview of immune checkpoint inhibitors, drug resistance, and adverse effects od Xuan-Yu Gu, Jinlong Huo, Zhiyong Yu, Ji-Chang Jiang, Yaxuan Xu, Lijin Zhao

    Izdano 2024
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:

Iskalna orodja: